TW201319572A - 類氨醯氧化酶樣2(lysyl oxidase-like 2)測定及其使用方法 - Google Patents

類氨醯氧化酶樣2(lysyl oxidase-like 2)測定及其使用方法 Download PDF

Info

Publication number
TW201319572A
TW201319572A TW101119847A TW101119847A TW201319572A TW 201319572 A TW201319572 A TW 201319572A TW 101119847 A TW101119847 A TW 101119847A TW 101119847 A TW101119847 A TW 101119847A TW 201319572 A TW201319572 A TW 201319572A
Authority
TW
Taiwan
Prior art keywords
loxl2
disease
antibody
level
individual
Prior art date
Application number
TW101119847A
Other languages
English (en)
Chinese (zh)
Inventor
Victoria Smith
Joanne I Adamkewicz
Susan K Lyman
Jason Chien
Xiaoming Li
Lixin Shao
Jeffrey D Bornstein
Original Assignee
Gilead Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW201319572(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics Inc filed Critical Gilead Biologics Inc
Publication of TW201319572A publication Critical patent/TW201319572A/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)
TW101119847A 2011-06-01 2012-06-01 類氨醯氧化酶樣2(lysyl oxidase-like 2)測定及其使用方法 TW201319572A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21

Publications (1)

Publication Number Publication Date
TW201319572A true TW201319572A (zh) 2013-05-16

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101119847A TW201319572A (zh) 2011-06-01 2012-06-01 類氨醯氧化酶樣2(lysyl oxidase-like 2)測定及其使用方法

Country Status (25)

Country Link
US (3) US20140206017A1 (enExample)
EP (1) EP2714744A1 (enExample)
JP (3) JP2014523521A (enExample)
KR (1) KR20140048156A (enExample)
CN (1) CN103946241A (enExample)
AP (1) AP2013007285A0 (enExample)
AR (1) AR086657A1 (enExample)
AU (2) AU2012261883A1 (enExample)
BR (1) BR112013030682A2 (enExample)
CA (1) CA2837534A1 (enExample)
CL (1) CL2013003445A1 (enExample)
CO (1) CO6940375A2 (enExample)
CR (1) CR20130657A (enExample)
EA (1) EA201391627A1 (enExample)
EC (1) ECSP13013092A (enExample)
IL (1) IL229631A0 (enExample)
MA (1) MA35212B1 (enExample)
MD (1) MD20130098A2 (enExample)
MX (1) MX2013013905A (enExample)
PE (1) PE20141450A1 (enExample)
PH (1) PH12013502490A1 (enExample)
TW (1) TW201319572A (enExample)
UY (1) UY34115A (enExample)
WO (1) WO2012167181A1 (enExample)
ZA (1) ZA201308812B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CA2693310C (en) * 2007-08-02 2018-11-27 Arresto Biosciences, Inc. Lox and loxl2 inhibitors, antibodies and uses thereof
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
CA2771702A1 (en) 2009-08-21 2011-02-24 Gilead Biologics, Inc. Catalytic domains from lysyl oxidase and loxl2
BR112012019693A2 (pt) 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
WO2014070939A1 (en) * 2012-10-30 2014-05-08 Gilead Sciences, Inc. Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
WO2015187499A1 (en) 2014-06-03 2015-12-10 Gilead Sciences, Inc. Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
EA201692202A1 (ru) 2014-06-11 2017-06-30 Джилид Сайэнс, Инк. Способы лечения сердечно-сосудистых заболеваний
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
JP2019510752A (ja) 2016-03-04 2019-04-18 ギリアード サイエンシーズ， インコーポレイテッド オートタキシン阻害剤の組成物及び合剤
JP2019513737A (ja) 2016-04-08 2019-05-30 ギリアード サイエンシーズ， インコーポレイテッド がん、炎症性疾患および自己免疫疾患を処置するための組成物および方法
GB201704206D0 (en) 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
US20230152330A1 (en) * 2021-11-17 2023-05-18 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CA2693310C (en) 2007-08-02 2018-11-27 Arresto Biosciences, Inc. Lox and loxl2 inhibitors, antibodies and uses thereof
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
RU2012110580A (ru) * 2009-08-21 2013-09-27 Джилид Байолоджикс, Инк. Способы скрининга in vivo
BR112012019693A2 (pt) * 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
US9556882B2 (en) * 2011-05-10 2017-01-31 Borgwarner Inc. Turbocharger with variable turbine geometry

Also Published As

Publication number Publication date
MX2013013905A (es) 2014-05-14
US20170269085A1 (en) 2017-09-21
AR086657A1 (es) 2014-01-15
KR20140048156A (ko) 2014-04-23
JP2016164578A (ja) 2016-09-08
IL229631A0 (en) 2014-01-30
AU2016244254A1 (en) 2016-11-03
MD20130098A2 (ro) 2014-06-30
AU2016244254B2 (en) 2018-10-18
JP2014523521A (ja) 2014-09-11
NZ618682A (en) 2016-04-29
BR112013030682A2 (pt) 2016-12-06
UY34115A (es) 2013-01-03
WO2012167181A1 (en) 2012-12-06
CL2013003445A1 (es) 2014-07-25
AU2012261883A1 (en) 2013-05-02
AP2013007285A0 (en) 2013-11-30
ZA201308812B (en) 2014-08-27
JP2018049033A (ja) 2018-03-29
EA201391627A1 (ru) 2014-08-29
CR20130657A (es) 2014-05-16
US20120309020A1 (en) 2012-12-06
CO6940375A2 (es) 2014-05-09
PH12013502490A1 (en) 2014-01-20
MA35212B1 (fr) 2014-06-02
EP2714744A1 (en) 2014-04-09
CN103946241A (zh) 2014-07-23
US20140206017A1 (en) 2014-07-24
CA2837534A1 (en) 2012-12-06
PE20141450A1 (es) 2014-11-06
ECSP13013092A (es) 2014-08-29

Similar Documents

Publication Publication Date Title
AU2016244254B2 (en) Lysyl oxidase-like 2 assay and methods of use thereof
US20170327595A1 (en) Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
AU2017294549B2 (en) Adrenomedullin for assessing congestion in a subject with acute heart failure
JP6812521B2 (ja) クロモグラニンａを検出するための免疫アッセイ法および抗体
JP2023518731A (ja) コロナウイルスに感染した患者におけるｄｐｐ３
JP2023516615A (ja) ショックを患っている患者におけるｎｔ－ａｄｍ抗体治療法ガイダンス、モニタリング、及び層別化のためのｄｐｐ３
US8247188B2 (en) FAS binding antibodies
Feng et al. Development of a monoclonal antibody-based time-resolved fluorescence immunochromatographic assay strip for rapid and quantitative determination of S100B in serum
JP7758661B2 (ja) 心不全を評価するためのアッセイ
NZ618682B2 (en) Lysyl oxidase-like 2 assay and methods of use thereof
WO2026070830A1 (ja) 線維化疾患の罹患の有無の判定方法
KR20220154743A (ko) 코로나 바이러스에 감염된 환자에서 프로-아드레노메둘린 또는 그의 단편, 및 아드레노메둘린에 대한 결합제에 의한 치료